You just read:

Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing

News provided by

Harmony Biosciences LLC and Bioprojet Pharma

Oct 06, 2017, 04:00 ET